ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
132.00
-4.74 (-3.47%)
At close: Mar 6, 2026, 4:00 PM EST
132.24
+0.24 (0.18%)
After-hours: Mar 6, 2026, 4:10 PM EST
ICU Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 2,231 | 2,382 | 2,259 | 2,280 | 1,316 | Upgrade
|
| Revenue | 2,231 | 2,382 | 2,259 | 2,280 | 1,316 | Upgrade
|
| Revenue Growth (YoY) | -6.33% | 5.44% | -0.92% | 73.21% | 3.56% | Upgrade
|
| Cost of Revenue | 1,409 | 1,557 | 1,519 | 1,582 | 824.82 | Upgrade
|
| Gross Profit | 822.04 | 824.78 | 739.87 | 697.76 | 491.49 | Upgrade
|
| Selling, General & Admin | 625.21 | 638.76 | 606.69 | 608.35 | 302.58 | Upgrade
|
| Research & Development | 87.5 | 88.62 | 85.34 | 92.98 | 47.5 | Upgrade
|
| Operating Expenses | 712.71 | 727.38 | 692.04 | 701.33 | 350.08 | Upgrade
|
| Operating Income | 109.33 | 97.41 | 47.84 | -3.57 | 141.41 | Upgrade
|
| Interest Expense | -93.34 | -106.54 | -102.73 | -70.81 | -0.86 | Upgrade
|
| Interest & Investment Income | 10.31 | 10.79 | 7.51 | 4.43 | 2.84 | Upgrade
|
| Earnings From Equity Investments | -1.19 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 3.79 | -9.79 | -5.92 | -5.78 | -1.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.35 | -1.82 | -2.43 | 3.2 | 0.63 | Upgrade
|
| EBT Excluding Unusual Items | 29.25 | -9.96 | -55.74 | -72.53 | 143 | Upgrade
|
| Merger & Restructuring Charges | -66.51 | -59.84 | -41.26 | -71.42 | -18.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | 40.43 | -1.61 | -0.15 | -2.55 | -1.65 | Upgrade
|
| Other Unusual Items | - | 5.4 | 16.25 | 32.09 | -0.13 | Upgrade
|
| Pretax Income | 3.17 | -66.01 | -78.3 | -114.41 | 123.19 | Upgrade
|
| Income Tax Expense | 2.44 | 51.68 | -48.64 | -40.12 | 20.05 | Upgrade
|
| Net Income | 0.73 | -117.69 | -29.66 | -74.29 | 103.14 | Upgrade
|
| Net Income to Common | 0.73 | -117.69 | -29.66 | -74.29 | 103.14 | Upgrade
|
| Net Income Growth | - | - | - | - | 18.72% | Upgrade
|
| Shares Outstanding (Basic) | 25 | 24 | 24 | 24 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 25 | 24 | 24 | 24 | 22 | Upgrade
|
| Shares Change (YoY) | 2.12% | 1.23% | 0.93% | 9.58% | 0.88% | Upgrade
|
| EPS (Basic) | 0.03 | -4.83 | -1.23 | -3.11 | 4.86 | Upgrade
|
| EPS (Diluted) | 0.03 | -4.83 | -1.23 | -3.11 | 4.74 | Upgrade
|
| EPS Growth | - | - | - | - | 17.91% | Upgrade
|
| Free Cash Flow | 91.8 | 124.66 | 82.31 | -152.44 | 199 | Upgrade
|
| Free Cash Flow Per Share | 3.69 | 5.11 | 3.42 | -6.39 | 9.14 | Upgrade
|
| Gross Margin | 36.84% | 34.63% | 32.75% | 30.60% | 37.34% | Upgrade
|
| Operating Margin | 4.90% | 4.09% | 2.12% | -0.16% | 10.74% | Upgrade
|
| Profit Margin | 0.03% | -4.94% | -1.31% | -3.26% | 7.83% | Upgrade
|
| Free Cash Flow Margin | 4.11% | 5.23% | 3.64% | -6.69% | 15.12% | Upgrade
|
| EBITDA | 310.08 | 316.92 | 276.61 | 231.58 | 231.11 | Upgrade
|
| EBITDA Margin | 13.90% | 13.30% | 12.24% | 10.16% | 17.56% | Upgrade
|
| D&A For EBITDA | 200.74 | 219.51 | 228.77 | 235.15 | 89.7 | Upgrade
|
| EBIT | 109.33 | 97.41 | 47.84 | -3.57 | 141.41 | Upgrade
|
| EBIT Margin | 4.90% | 4.09% | 2.12% | -0.16% | 10.74% | Upgrade
|
| Effective Tax Rate | 76.90% | - | - | - | 16.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.